Acadia Pharmaceuticals Inc. (ACAD)

[IanFromSI]

I agree completely. In addition, all of the buy side analysts that I've seen have lowered their price targets but reiterated their ratings. An overwhelming majority still has ACAD at strong buy.

April 3rd will be a binary decision date. The FDA has already approved, reviewed and confirmed approval for psychosis tx.

MDD not reaching stat sig reaction is quite probably overdone. The medical caregivers have already seen how it has helped their Parkinson's pts. There was never going to be a Nuplazid rx for psychosis and a separate one for MDD. I.e. It was always going to be one or the other or none.

So even if MDD isn't added to the label for dementia related Psychosis, the doctors will still try it, especially if ACAD continues its 30 day free trial for new pts, and we'll see nearly the same total sales anyway.

Assuming ACAD gets the April 3rd approval, it may take the market a quarter or 2 to get a handle on the new sales rate.

JMHO,Ian